Valtecne SpA

Valtecne SpA Net Margin

The Net Profit Margin of Valtecne SpA (VLT.MI) as of Oct 22, 2026 is 11.63 %. In the previous year, Net Profit Margin was 11.25 % — a change of 3.45% (higher).

Net Margin

11.63 %

YoY

3.45%

Last updated:

Net Profit Margin of Valtecne SpA is 2025 11.63 % . Net Profit Margin of Valtecne SpA was 2024 11.25 % . It decreases by 3.45% higher compared to the previous year.

Valtecne SpA's net margin stands at 11.6%, up from 9.3% several years earlier.

The Valtecne SpA Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
9.66 EUR
Jan 1, 2020
6.37 EUR
Jan 1, 2021
9.26 EUR
Jan 1, 2022
9.86 EUR
Jan 1, 2023
10.36 EUR
Jan 1, 2024
11.25 EUR
Jan 1, 2025
11.63 EUR
The Valtecne SpA Net Margin history
YEARNet MarginYoY
11.63 %+3.45%
11.25 %+8.60%
10.36 %+5.07%
9.86 %+6.45%
9.26 %+45.44%
6.37 %-34.09%
9.66 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valtecne SpA Stock analysis

What does Valtecne SpA do? Valtecne SpA produces precision-machined mechanical components for orthopedic and veterinary surgery, including cutting guides, pin pliers, femoral sizers, and tibial resection guides. The company also manufactures implantable devices such as femoral stems, femoral heads, stem collars, and tibial implants. These products are sold globally to medical device manufacturers and healthcare providers specializing in orthopedic and veterinary care. Valtecne SpA generates revenue through the sale of these high-precision surgical instruments and implantable devices to international medical markets. The company operates in the precision-machined sector, focusing on specialized instruments for orthopedic and veterinary surgery. Its product range includes both surgical tools like cutting guides and implantable components such as femoral stems. Valtecne SpA's global operations ensure its products reach medical device companies and clinics worldwide, supporting the production of advanced surgical solutions. Valtecne SpA's revenue model is based on manufacturing and selling precision-machined components for medical applications. The company's key products are surgical instruments and implantable devices used in orthopedic and veterinary procedures. By targeting medical device manufacturers and healthcare providers, Valtecne SpA secures contracts for its high-precision components, which are essential for surgical procedures and patient care. Valtecne SpA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valtecne SpA stock

Net Profit Margin of Valtecne SpA is 11.63 % in 2025.

Net Profit Margin of Valtecne SpA changed from 11.25 % to 11.63 %, representing a 3.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Valtecne SpA since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Valtecne SpA with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Valtecne SpA

All Key Metrics — Valtecne SpA